Afuco™ Anti-CD27 ADCC Therapeutic Antibody (Varlilumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human CD27. Varlilumab is an immunotherapy designed to enhance the body's natural immune response by directly activating T cells that can specifically recognize and kill cancer cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-H74 |
| Pricing | Inquiry |
| Host | Human |
| Target | CD27 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IP, FC, FuncS, Neut, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |